MCAM and neoplasm: As well as expression on vascular cells, CD146 is also expressed on the malignant cells of the tumour and de Kruijff et al. showed that high levels of CD146 on malignant breast cancer cells is indicative of poor patient outcomes (De Kruijff et al., 2018).